Stan V. Smith - 31 Dec 2025 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Stan V. Smith
Issuer symbol
MAIA
Transactions as of
31 Dec 2025
Net transactions value
$0
Form type
4
Filing time
05 Jan 2026, 08:42:31 UTC
Previous filing
23 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Smith Stan Director 444 WEST LAKE STREET, SUITE 1700, CHICAGO /s/ Stan V. Smith 05 Jan 2026 0001913199

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Options Award $0 +29,216 $0.000000 29,216 31 Dec 2025 Common Stock 29,216 $1.53 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
F2 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.